Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex.
about
SMYD1, the myogenic activator, is a direct target of serum response factor and myogeninHRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivoMyofibroblasts: trust your heart and let fate decide.Human SM22 alpha BAC encompasses regulatory sequences for expression in vascular and visceral smooth muscles at fetal and adult stagesDifferential binding of an SRF/NK-2/MEF2 transcription factor complex in normal versus neoplastic smooth muscle tissuesCryptic MCAT enhancer regulation in fibroblasts and smooth muscle cells. Suppression of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Pur alpha, Pur beta, and MSY1Recruitment of the androgen receptor via serum response factor facilitates expression of a myogenic genePIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins.Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factorTranscriptional regulation of a contractile gene by mechanical forces applied through integrins in osteoblastsKruppel-like factor 4, Elk-1, and histone deacetylases cooperatively suppress smooth muscle cell differentiation markers in response to oxidized phospholipids.The homeodomain protein Barx2 promotes myogenic differentiation and is regulated by myogenic regulatory factorsSmooth muscle differentiation marker gene expression is regulated by RhoA-mediated actin polymerization.Smooth muscle cell phenotypic switching in atherosclerosisPlatelet-derived growth factor-BB and Ets-1 transcription factor negatively regulate transcription of multiple smooth muscle cell differentiation marker genes.Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo.Regulation of alpha-smooth muscle actin expression in granulation tissue myofibroblasts is dependent on the intronic CArG element and the transforming growth factor-beta1 control element.Laser microdissection-based analysis of mRNA expression in human coronary arteries with intimal thickening.HeliCis: a DNA motif discovery tool for colocalized motif pairs with periodic spacing.A robust and sensitive synthetic sensor to monitor the transcriptional output of the cytokinin signaling network in planta.Prediction of cell type-specific gene modules: identification and initial characterization of a core set of smooth muscle-specific genes.Weak up-regulation of serum response factor in gastric ulcers in patients with co-morbidities is associated with increased risk of recurrent bleedingCombinatorial expression of GATA4, Nkx2-5, and serum response factor directs early cardiac gene activity.Myocardin-related transcription factors A and B are key regulators of TGF-β1-induced fibroblast to myofibroblast differentiation.Cell contact-dependent regulation of epithelial-myofibroblast transition via the rho-rho kinase-phospho-myosin pathway.Modulation of human valve interstitial cell phenotype and function using a fibroblast growth factor 2 formulationCellular and Molecular Mechanisms of Phenotypic Switch in Gastrointestinal Smooth Muscle.SMYD1, an SRF-Interacting Partner, Is Involved in Angiogenesis.STAT3 Protein Regulates Vascular Smooth Muscle Cell Phenotypic Switch by Interaction with Myocardin.Regulation of smooth muscle differentiation by the myocardin family of serum response factor co-factors.Epigenetics in atherosclerosis and inflammation.Antifibrotic effects of noscapine through activation of prostaglandin E2 receptors and protein kinase A.Epigenetic regulation of vascular smooth muscle cell function in atherosclerosis.Structure/function analysis of mouse Purbeta, a single-stranded DNA-binding repressor of vascular smooth muscle alpha-actin gene transcription.MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration.Enhancement of mDia2 activity by Rho-kinase-dependent phosphorylation of the diaphanous autoregulatory domain.Targeting myofibroblasts in model systems of fibrosis by an artificial alpha-smooth muscle-actin promoter hybrid.Formin homology domain-containing protein 1 regulates smooth muscle cell phenotype.PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression.Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation.
P2860
Q24318909-A9D25575-4398-4659-A105-CE8B6EA0C458Q24623607-BDB2CC81-687E-48B4-894C-921092EBA905Q27692541-34381F91-C80B-4179-A39F-DF1DB1E3A6D7Q28202492-3BA7AB23-9BA1-4528-AC8F-3B3A98E74E2AQ28206982-E3ED9565-0E14-45EE-99C4-D1964C6AC089Q28212829-E5C41C71-514E-48CD-8564-7261D333DE69Q28300387-917ED689-8ADA-4E30-9F35-1D911D33CB7FQ28569320-572910AA-8A18-4C2E-94FD-4609F1F43EB8Q28572551-8FF9D002-22A4-40E5-86C0-FE26F8506D73Q28573090-CFE290F8-929C-4838-ADE4-057E1C08C6ECQ28579612-16BF8962-8170-4B16-98F7-6957C41E5FC6Q28583372-C5204E8A-EB44-4063-81F2-0A536B007C8DQ30306237-D8A152AB-9485-4713-AE55-88B0D571BF22Q30418243-09B0C11C-13AA-462A-9231-70FB5DFA6F5BQ30432867-D152EB32-049C-43AB-8BC6-8EC04F1A7967Q30439134-4451E819-92B2-4EB1-8C42-7BDD8F470C77Q30445150-08039E8D-545F-443F-AAC2-DB10DB85A8EBQ33208292-AA4323E1-D32D-4A84-92A2-AD5AA15331A8Q33304056-87BD3A0F-A23D-4D0D-BC9B-11EDD78DAE29Q33355177-7F8576E7-1344-4C3F-AD1F-E4DE9BF60FF7Q33682607-6D2A8F2E-F443-44BE-99FB-EF4C3EBE9359Q33848591-C6C54055-CE7F-4CA1-BE80-B7C93EB29C6DQ34126121-BD1D6DA1-1E41-421E-90F9-728240517E6AQ35417672-D10166F3-A6D9-408C-9F22-A4A40E07C699Q35650846-BD05B679-24FC-4951-9A1A-220F7A82BBEBQ35652563-CA711AA1-5355-4CB8-82E0-7A80855A6C54Q35709811-6C9489A6-7A42-4A1B-8D78-FBCC4CAC9F77Q35901433-AC251167-4CAB-429A-B110-174F47EBAD4FQ35925825-0D8AFC45-3C79-4756-AE1D-9D2679C9523AQ36126950-38450FAB-F232-4C89-9DFB-EAE48C3CD496Q37310578-DE23A3A2-C34A-4C19-B9FF-6ED61BBAE208Q37635787-CE2A463F-CF1D-4F02-A68C-9F7B52220EF6Q38083011-78C5D5B4-34E9-4999-A3E4-9B917D4A1E08Q38352352-179A8CA0-8D19-4C9D-BD84-8EC70CEE02ABQ38353674-AC964164-8611-4AF3-BF5C-1F58F1D77F17Q39519441-6150ACA0-82DC-4F67-AA65-DA0DD1583B62Q39833975-CF6F0FAB-AD50-4DDE-84CB-46FA89DE2D67Q41981014-0B7FC245-45EF-4A22-B405-49DE7D5B525AQ42246031-B1A1790A-585F-47E7-8517-CB85DB48D324Q42290035-09E8C9EF-E75B-4F89-8E7D-11FB7B873984
P2860
Smooth muscle alpha-actin CArG elements coordinate formation of a smooth muscle cell-selective, serum response factor-containing activation complex.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Smooth muscle alpha-actin CArG ...... containing activation complex.
@ast
Smooth muscle alpha-actin CArG ...... containing activation complex.
@en
type
label
Smooth muscle alpha-actin CArG ...... containing activation complex.
@ast
Smooth muscle alpha-actin CArG ...... containing activation complex.
@en
prefLabel
Smooth muscle alpha-actin CArG ...... containing activation complex.
@ast
Smooth muscle alpha-actin CArG ...... containing activation complex.
@en
P2093
P356
P1433
P1476
Smooth muscle alpha-actin CArG ...... containing activation complex.
@en
P2093
Lawrenz-Smith S
Thompson MM
P304
P356
10.1161/01.RES.86.2.221
P577
2000-02-01T00:00:00Z